MedTrace Logo

Drug Coated Ballon in Critical Limb Ischemia

NCT04737291 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2021-02-03

No results posted yet for this study

Summary

Evaluate the safety and efficacy of drug coated balloon (DCB) for the treatment of femoropopliteal lesions in patients with critical limb ischemia (CLI)

Conditions

  • Drug Coated Balloon

Interventions

DEVICE

drug coated balloon

use of drug coated balloon in treatment of critical limb ischemia

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • hassan bakr, professor · Assiut University

  • mahmoud ismael, ass profesor · Assiut University

  • osman mahmoud, lecturer · Assiut University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-15
Primary Completion
2022-03-31
Completion
2023-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04737291 on ClinicalTrials.gov